[HTML][HTML] Protocol: Assessing the unmet needs of patients with advanced cancer treated by biological and precision therapies: protocol for TARGET, a mixed methods …
L Crowe, M Brown, A Bojke, R Bojke, A Greystoke… - BMJ Open, 2023 - ncbi.nlm.nih.gov
Introduction Biological and precision therapies are increasingly used in cancer treatment.
Although they may improve survival, they are also associated with various—and unique …
Although they may improve survival, they are also associated with various—and unique …
Assessing the unmet needs of patients with advanced cancer treated by biological and precision therapies: protocol for TARGET, a mixed methods study
L Crowe, M Brown, A Bojke, R Bojke, A Greystoke… - BMJ open, 2023 - bmjopen.bmj.com
Introduction Biological and precision therapies are increasingly used in cancer treatment.
Although they may improve survival, they are also associated with various—and unique …
Although they may improve survival, they are also associated with various—and unique …
Novel methodology for comparing standard-of-care interventions in patients with cancer
J Hilton, S Mazzarello, D Fergusson, AA Joy… - Journal of Oncology …, 2016 - ascopubs.org
Purpose: The current clinical trials development and conduct process is cumbersome and
expensive, with the majority of studies focusing on either the development of new agents or …
expensive, with the majority of studies focusing on either the development of new agents or …
[HTML][HTML] Precision oncology medicines and the need for real world evidence acceptance in health technology assessment: Importance of patient involvement in …
J Geissler, LE Makaroff, B Söhlke… - European Journal of …, 2023 - Elsevier
Precision oncology has made remarkable strides in improving clinical outcomes, offering
hope to patients with historically difficult-to-treat, as well as rare or neglected cancers …
hope to patients with historically difficult-to-treat, as well as rare or neglected cancers …
P92 Experiences of patients treated with biological and precision therapies: qualitative findings from the TARGET study
Background Biological and precision therapies have the potential to transform prognosis of
patients diagnosed with advanced cancer. Their availability has exploded in recent years …
patients diagnosed with advanced cancer. Their availability has exploded in recent years …
OP44 Exploring unmet needs in biological and precision therapy cancer patients: Developing a supportive care needs assessment. Findings from the TARGET Study
Background Biological and precision therapies (known as targeted therapies) have been a
significant success in the treatment of metastatic cancer. The number licenced is continually …
significant success in the treatment of metastatic cancer. The number licenced is continually …
Comment on “Redefining cancer research for therapeutic breakthroughs”
P Cooray - British Journal of Cancer, 2024 - nature.com
While we as clinicians strive to obtain best possible outcomes for our patients, there is a risk
that adhering to a system that has brought significant breakthroughs in cancer may not be …
that adhering to a system that has brought significant breakthroughs in cancer may not be …
Unmet care needs in people living with advanced cancer: a systematic review
N Moghaddam, H Coxon, S Nabarro, B Hardy… - Supportive care in …, 2016 - Springer
Purpose The support needs of cancer patients vary according to the phase of their cancer
journey. Recent developments in healthcare are such that the advanced cancer phase is …
journey. Recent developments in healthcare are such that the advanced cancer phase is …
What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?
IN Olver, IE Haines - Medical Journal of Australia, 2009 - Wiley Online Library
In this 21st century, we will need to better analyse the outcomes of our spending on newer
and more expensive anticancer drugs, particularly through postmarketing assessment, to …
and more expensive anticancer drugs, particularly through postmarketing assessment, to …
[HTML][HTML] Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition
The Bloomberg New Economy International Cancer Coalition brings together academia,
industry, government, patient advocacy and policy think tanks to leverage technology and …
industry, government, patient advocacy and policy think tanks to leverage technology and …